Beta blocking agents: current status in the prevention of sudden coronary death.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000526:Alprenolol / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D003645:Death, Sudden / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D011217:Practolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011446:Prospective Studies; D011897:Random Allocation; D013999:Timolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D001262:Atenolol; D013999:Timolol; D000526:Alprenolol; D011433:Propranolol; D008790:Metoprolol; D011217:Practolol